Avenue Therapeutics Inc (NASDAQ:ATXI)

1.28
Delayed Data
As of 3:59pm ET
 -0.03 / -2.29%
Today’s Change
1.06
Today|||52-Week Range
18.75
+10.34%
Year-to-Date
Institutional investors purchased a net $295.5 thousand shares of ATXI during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 12.84% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Other institutional12.53%
Individual stakeholders11.76%
Mutual fund holders0.31%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

12/31/2022SABBY MANAGEMENT LLC  Bought 264.0 Thousand shares of Avenue Therapeutics Inc

Top 10 Owners of Avenue Therapeutics Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Heights Capital Management, Inc.5.71%272,700316,33200.00%
Sabby Management LLC5.53%264,000306,240+264,000--
Citadel Securities LLC0.75%35,86541,603+35,865--
Two Sigma Investments LP0.30%14,34216,637+14,342--
Two Sigma Securities LLC0.30%14,15916,424+12,415+711.87%
Wells Fargo Clearing Services LLC0.10%4,5335,25800.00%
BlackRock Fund Advisors0.04%1,8672,166-4-0.21%
Morgan Stanley & Co. LLC0.03%1,4741,710+1,474--
Tower Research Capital LLC0.03%1,4251,653+1,216+581.82%
UBS Securities LLC0.02%1,1381,320-985-46.40%

Top 10 Mutual Funds Holding Avenue Therapeutics Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Vanguard Extended Market Index Fu...0.18%8,3359,66900.00%
Fidelity Extended Market Index Fu...0.07%3,5114,07300.00%
Fidelity Nasdaq Composite Index F...0.03%1,2721,47600.00%
iShares Core S&P Total US Stock M...0.01%51359500.00%
Fidelity Total Market Index Fund0.01%41147700.00%
Fidelity Series Total Market Inde...0.01%29434100.00%
Vanguard Invt. Fds. ICVC - US Equ...0.00%15918400.00%